Showing results (151-160 of 168) with videos related to
Sort By:
Pageof 17
Therapie|March 1, 1989
[Pharmacokinetics of oral propafenone in patients with supraventricular arrhythmia]A Buoncuore, J M Poirier, P Jaillon, et al.Circulation Research|April 1, 1982
The effects of diltiazem and reduced serum ionized calcium on ischemic ventricular fibrillation in the dogW T Clusin, M R Bristow, D S Baim, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|April 1, 1985
[Electrophysiological effects of intravenous sotalol. Relation with plasma levels]P Dumoulin, J Weissenburger, J M Poirier, et al.The Journal of Antimicrobial Chemotherapy|April 1, 1989
Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patientsJ D Grange, A Gouyette, L Gutmann, et al.European Journal of Clinical Pharmacology|April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?S Morin, M A Loriot, J M Poirier, et al.European Journal of Clinical Pharmacology|March 14, 2003
Genetic and environmental risk factors for oral anticoagulant overdoseC Verstuyft, A Robert, S Morin, et al.Clinical Pharmacology and Therapeutics|March 1, 1990
Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patientsA Rames, J M Poirier, F LeCoz, et al.Journal of Cardiovascular Pharmacology|October 1, 1988
Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administrationB Lecocq, P Jaillon, V Lecocq, et al.Annales De Biologie Clinique|June 14, 2003
[A new, rapid and robust genotyping method for CYP2C9 and MDR1]C Verstuyft, S Morin, J Yang, et al.Clinical Pharmacology and Therapeutics|August 1, 1989
Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patientsP Jaillon, M E Gardin, B Lecocq, et al.Pageof 17